https://doi.org/10.4081/reumatismo.2022.1520
Rheumatology research output in the Arab World: despite the challenges
Accepted: 3 October 2022
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Rheumatology is a field in which diagnostic, pathophysiological, and therapeutic advancements occur daily. These developments are the result of research in basic sciences, translational sciences, and clinical sciences. Physical and financial support, provided by individuals and institutions, is essential for all types of research. The political and economic instability in the Arab world has impacted the advancement of healthcare and the output of research. This review seeks to evaluate the quantity and quality of rheumatology-related research conducted in the Arab world. This review examined the number of rheumatological clinical publications produced by Arab countries between 2017 and 2021 and cited by PubMed/MEDLINE. Publications with authors from multiple nations were disqualified. Publications were then categorized by type, including randomized controlled trials (RCTs), cohort studies, cross-sectional studies, systematic reviews, narrative reviews, and case reports. Publications were also organized according to the regions of the Arab world: North and East Africa, the Middle East, and the Arabian Peninsula. The review also used data from the world bank to evaluate the gross domestic product (GDP) and total population of Arabian nations in order to calculate a ratio of publications to GDP and publications to population. Egypt had the highest number of publications among north and east African countries and Arab countries in general, with 261 publications, including the highest number of RCTs, which were 23. With 81 publications, Saudi Arabia had the highest number of publications on the Arabian peninsula. However, no individual country on the Arabian peninsula published an RCT. Lebanon had the most publications in the Middle East, but the majority were reviews and case reports. Tunisia had the highest ratio of publications to GDP. Notably, the number of publications increased during the coronavirus disease 2019 era in some countries. The Arab world is still able to produce clinical rheumatology publications despite its political instability and lack of resources. The influence of such publications on the daily practice of rheumatology is still debatable.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Similar Articles
- V. Bruzzese, P. Scolieri, J. Pepe, Efficacy of gluten-free diet in patients with rheumatoid arthritis , Reumatismo: Vol. 72 No. 4 (2020)
- M.E. Tezcan, B. Isci, Pulmonary multiple cystic lesions in a patient with Behçet’s syndrome , Reumatismo: Vol. 71 No. 2 (2019)
- J. Uson, E. Naredo, Snap-shot of the ultrasound school of the Spanish Society of Rheumatology , Reumatismo: Vol. 57 No. 1 (2005)
- F.M. Galassi, L. Ingaliso, V. Papa, R. Lorenzi, E. Percivaldi, E. Varotto, On the early uses of the word ‘gout’: novel evidence and a critical assessment of the published literature , Reumatismo: Vol. 76 No. 2 (2024)
- S. Sülükcü, S. Uslu, Assessment of liver and kidney function in patients with ankylosing spondylitis on long-term non-steroidal anti-inflammatory drug therapy , Reumatismo: Early Access
- F.I. Gorial, N.I. Awadh, A.D. Al-Obaidi, M.N. Al-Obaidi, H.T. Hashim, H.J. Hasan, Post-streptococcal scleredema an unusual rare mimicker of scleroderma: a case report , Reumatismo: Vol. 75 No. 1 (2023)
- F. Salaffi, C.M. Vaccaro, T. Manacorda, L. Pardini, C.M. Montecucco, Socio-demographic aspects and therapeutic pathways in patients with rheumatoid arthritis in Italy , Reumatismo: Vol. 61 No. 3 (2009)
- G. El Hasbani, A. Jawad, I. Uthman, Axial and peripheral spondyloarthritis triggered by sars-cov-2 infection: a report of two cases , Reumatismo: Vol. 73 No. 1 (2021)
- B. Maranini, G. Ciancio, R. Cultrera, M. Govoni, Reply to: “Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab” by Josef Finsterer , Reumatismo: Vol. 74 No. 1 (2022)
- M.A. Mortada, L.I. Kotb, Y.A. Amer, Impact of ultrasonography detected quadriceps calcific tendinopathy on pain and function in patients with primary knee osteoarthritis , Reumatismo: Vol. 73 No. 2 (2021)
<< < 24 25 26 27 28 29 30 31 32 33 > >>
You may also start an advanced similarity search for this article.
